Jobs / United States / Novartis Pharmaceuticals Corporation
Field Access Manager
Novartis Pharmaceuticals Corporation · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles5 certified filings for “Finance Manager” (Financial Quantitative Analysts) in NJ: $73k–$113k, median $113k. Most were filed at wage level II (60%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary #LI-Hybrid The Field Access Manager leads the execution of access strategies at national, regional and hospital levels to support the inclusion, reimbursement and availability of Novartis priority therapies. The role develops and implements strategies that facilitate adoption across public and private institutions, removes access barriers and creates opportunities for patients. It manages strategic accounts and key stakeholders, supports purchasing, contracting and demand-planning processes, and advances evidence-based value propositions through cross-functional collaboration to demonstrate the clinical, economic and health-system impact of Novartis solutions and accelerate sustainable access. This role is based in Guayaquil, Ecuador. Novartis is unable to offer relocation support for this role: please only apply if this location is accessible for you. Job Description Key responsibilities • Develop and execute national, regional and institutional access strategies that support the timely and sustainable inclusion, reimbursement and availability of priority Novartis therapies. • Identify, map and prioritize key decision-makers across health authorities, public payers, hospitals, pharmacy, procurement, planning and clinical leadership, and implement focused engagement plans in line with compliance requirements. • Build trusted relationships with strategic public and private accounts to open new opportunities, strengthen institutional inclusion and support sustainable patient-access pathways. • Lead or support negotiations, tenders, contracting, public procurement and institutional purchasing processes while protecting the value proposition throughout the product life cycle. • Assess financing, budgeting, formulary, reimbursement and acquisition pathways, identify access barriers and drive practical solutions that accelerate treatment availability for patients. • Design and communicate evidence-based value propositions that demonstrate the clinical, economic and health-system impact of Novartis solutions. • Lead cross-functional initiatives without direct authority, aligning Value & Access, Medical, HEOR, Commercial, Public Affairs, Government Affairs, Pricing, Legal and Compliance around shared access objectives. • Contribute to Healthcare System Shaping initiatives by translating market and account insights into strategic plans that strengthen access and business sustainability. • Use data, account insights and strategic planning to prioritize opportunities, forecast institutional demand and monitor execution across complex, long-cycle access processes. • Measure impact through institutional activation, product inclusion in purchasing or budget processes, stakeholder engagement and the number of patients gaining access through formal mechanisms. Essential Requirements • Relevant university education, professional proficiency in Spanish, and demonstrated experience in institutional market access, public healthcare, strategic account management, government affairs or institutional KAM roles; depth of experience should be appropriate to the scope of the position. • Strong knowledge of the Ecuadorian healthcare system, including public-sector financing, budgeting, institutional inclusion, reimbursement, procurement and patient-access pathways. • Demonstrated ability to identify, prioritize and engage senior stakeholders across MSP, IESS, ISSFA, ISSPOL, hospitals, pharmacy, procurement, planning and clinical leadership, always within required compliance standards. • Proven negotiation, influencing and executive communication skills, including the ability to lead outcomes without formal authority. • Strategic thinking and strong results orientation, with success measured through